September 30, 2022
2 min watch
Save
VIDEO: SpyGlass CEO gives update on IOP-lowering drug delivery platform
CHICAGO — In this video from Eyecelerator@AAO, SpyGlass Pharma CEO Patrick Mooney discusses the company’s drug delivery platform, which lowered IOP in patients with open-angle glaucoma or ocular hypertension.
“We’re all about long-term drug delivery, and our long-term drug delivery platform gives the physicians the ability to treat patients and gives patients a little holiday from their drops,” he said.
Published by:
Sources/Disclosures
Collapse
Source:
Mooney P. SpyGlass Pharma. Presented at: Eyecelerator@AAO; Sept. 29, 2022; Chicago.
Disclosures:
Mooney reports being the CEO of SpyGlass Pharma.
Read more about